Mukesh M. Agarwal

Prof. Mukesh M. Agarwal

California University of Science and Medicine
orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2015 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Open access
MHMoshe Hod
Moshe Hod
AKAnil Kapur
Anil Kapur
DSDavid A. Sacks
David A. Sacks
EHEran Hadar
Eran Hadar
MAMukesh M. Agarwal
Mukesh M. Agarwal
HDHema Divakar
Hema Divakar

2 June 2010 in Diabetes Care
Verified
Journal Article
Open access
MAMukesh M. Agarwal
Mukesh M. Agarwal
GDGurdeep S. Dhatt
Gurdeep S. Dhatt
SSSyed M. Shah
Syed M. Shah
OBJECTIVE: To determine the impact of the International Association of Diabetes and Pregnancy Study Group (IADPSG) criteria on 1) gestational diabetes mellitus (GDM) diagnosis compared with the American Diabetes Association (ADA) criteria and 2) the fasting plasma glucose (FPG) to predict GDM. RESEARCH DESIGN AND METHODS: In 10,283 pregnant women undergoing a 75-g oral glucose tolerance test (OGTT) for universal screening of GDM, two FPG thresholds (of the OGTT) were used to rule in and to rule out GDM. RESULTS: The IADPSG and ADA criteria identified GDM in 3,875 (37.7%) women and 1,328 (12.9%) women, respectively (P < 0.0005). FPG thresholds of ≥5.1 mmol/l ruled in GDM in 2,975 (28.9%) women with 100% specificity, while <4.4 mmol/l ruled out GDM in 2,228 (21.7%) women with 95.4% sensitivity. FPG independently could have avoided the OGTT in 5,203 (50.6%) women. CONCLUSIONS: The IADPSG criteria increased GDM prevalence nearly threefold. By circumventing a significant number of OGTTs, an initial FPG can greatly simplify the IADPSG diagnostic algorithm.

1 December 2007 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
HSHussein Saadi
Hussein Saadi
SCS. George Carruthers
S. George Carruthers
NNNicolaas Nagelkerke
Nicolaas Nagelkerke
FAFatma Al-Maskari
Fatma Al-Maskari
BABachar Afandi
Bachar Afandi
SBSheela Benedict
Sheela Benedict

30 August 1986 in BMJ
Verified
Journal Article
Closed access
PDF file
NBN Blumberg
N Blumberg
JHJ M Heal
J M Heal
PMP Murphy
P Murphy
MAMukesh M. Agarwal
Mukesh M. Agarwal
CCC Chuang
C Chuang
Transfusion affects the immune response to renal transplantation and may be associated with recurrence of various human neoplasms. Data from patients with colonic, rectal, cervical, and prostate tumours showed an association between transfusion of any amount of whole blood or larger amounts of red blood cells at the time of surgery and later recurrence of cancer. Recipients of one unit of whole blood had a significantly higher incidence of recurrence (45%) than recipients of a single unit of red cells (12%) (p = 0.03). Recipients of two units of whole blood also had a higher rate of recurrence (52%) than those receiving two units of red cells (23%) (p = 0.03). Recipients of any amount of whole blood had similar recurrence rates (38-52%). Recipients of four or more units of red blood cells had a higher rate of recurrence (55%) than those receiving three or fewer units of red blood cells (20%) (p = 0.005). Mortality due to cancer in patients receiving three or fewer units of red blood cells (2%) was similar to that in patients who did not have transfusions (7%) and significantly lower than that observed in patients receiving three or fewer units of whole blood (20%) (p = 0.003). A proportional hazards risk analysis showed that transfusion of any whole blood or more than three units of red blood cells was significantly associated with earlier recurrence and death due to cancer. These data support an association between transfusion and recurrence of cancer. They also suggest that some factor present in greater amounts in whole blood, such as plasma, may contribute to the increased risk of recurrence in patients who have undergone transfusion. Until the questions raised by retrospective studies of cancer recurrence and transfusion can be answered by prospective interventional trials with washed red blood cells, red blood cells should be transfused to patients with cancer in preference to whole blood when clinically feasible.

1 February 2003 in The Journal of Pediatrics
Verified
Journal Article
Closed access
ADAdekunle Dawodu
Adekunle Dawodu
MAMukesh M. Agarwal
Mukesh M. Agarwal
MHMoshaddeque Hossain
Moshaddeque Hossain
JKJose Kochiyil
Jose Kochiyil
RZReem Zayed
Reem Zayed

1 March 2014 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
SCStephen Colagiuri
Stephen Colagiuri
MFMaicon Falavigna
Maicon Falavigna
MAMukesh M. Agarwal
Mukesh M. Agarwal
MBMichel Boulvain
Michel Boulvain
ECEdward Coetzee
Edward Coetzee
HYHuixia Yang
Huixia Yang